|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest income, net | |||
| Other income (expense), net | |||
| Total other income (expense), net | |||
| Net loss | |||
| Unrealized gain (loss) on available for sale securities | |||
| Total comprehensive loss | |||
| Net loss per share attributable to common stockholders, basic | |||
| Net loss per share attributable to common stockholders, diluted | |||
| Weighted-average common shares outstanding, basic | |||
| Weighted-average common shares outstanding, diluted |
Loading...
